Lakefront Biotherapeutics | GLPG - Net Income

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR14.49M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
argenx SE USD 366M 166.95M Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
Biogen USD 319.5M 368.4M Mar/2026
Genmab DKK 31M 370M Dec/2025
Gilead Sciences USD 2.02B 162M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Incyte USD 303.33M 4.05M Mar/2026
Merck EUR 319M 583M Dec/2025
Neurocrine Biosciences USD 197.9M 44.2M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
UCB EUR 1.08B 608M Dec/2025
Vertex Pharmaceuticals USD 1.03B 159.7M Mar/2026